Fig. 1From: Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment a Shows plots with 95% confidence interval of the average T-scores of the symptoms of each treatment group while undergoing HCV therapy. b Illustrates plots with 95% confidence intervals of the symptom scores when patients were dichotomized based on their hepatitis C treatment premature discontinuation status due to adverse events or lost to follow-upBack to article page